Journals / Retina-Vitreus / 2005 / Cilt: 13 - Sayı: 3

The effect of intravitreal triamcynolone injection on short term intraocular pressure

Vitreus içi triamsinolon uygulamasının erken dönem göz içi basıncı'na etkisi

Pages
215–217
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Anterior chamber paracentesis is not necessary after the injections.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: To evaluate the short term intraocular pressure (IOP) changes after intravitreal injection of triamcinolone acetonide (4mg/0.1ml).
📊
Key Findings & Data:Materials and Methods: The study included 20 eyes of 20 patients with diffuse diabetic macular edema (14 eyes), exudative age related macular degeneration (5 eyes), psuedophacic cystoid macular edema (1 eye) who received an intravitreal injection of 4 mg/0.1 triamcinolone acetonide.
💡
Conclusion & Impact:Anterior chamber paracentesis is not necessary after the injections.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Maküler dejenerasyon · Maküler ödem · sistoid

Abstract

Purpose: To evaluate the short term intraocular pressure (IOP) changes after intravitreal injection of triamcinolone acetonide (4mg/0.1ml). Materials and Methods: The study included 20 eyes of 20 patients with diffuse diabetic macular edema (14 eyes), exudative age related macular degeneration (5 eyes), psuedophacic cystoid macular edema (1 eye) who received an intravitreal injection of 4 mg/0.1 triamcinolone acetonide. The IOPs before injection were recorded by Tonopen XL. IOP was measured 30 minutes, 2 hours, 3 hours, 5 hours and 1 week after the injection. The relationship between the changes of IOP and time were evaluated by two-way ANOVA Results: Mean age of the patients was 61.7±6.9. Mean IOP was 18.3±2.8 mm Hg before the injection. IOP was 18.1 ± 3.6 mm Hg on 30th minutes, 19.1 ± 2.9 mmHg on 2nd hours, 18.5± 3.4 mm Hg on 5th hours and 17.3 ± 2.4 mm Hg on 1st week after the injection. The difference between the mean pre-injection IOP and the mean post-injections IOP in different times was not statistically significant. (p>0.05) Conclusion: After intravitreal injections of 4 mg/0.1 ml of triamcinolone acetonide, marked elevations in IOP are not seen in short term. Anterior chamber paracentesis is not necessary after the injections.

Özet

Amaç: Vitreus içi triamsinolon asetonid enjeksiyonundan sonra (4 mg/0.1 ml) erken dönem göziçi basıncı (GİB) değişikliklerini değerlendirmek. Gereç ve Yöntem: Çalışmaya, diffüz diyabetik makula ödemi (14 göz), eksüdatif yaşa bağlı makula dejenerasyonu (5 göz) ve psödofakik kistoid makula ödemi (1 göz) nedeniyle vitreus içi 4 mg/0.1 triamsinolon asetonid yapılan 20 hastanın 20 gözü alındı. Enjeksiyondan önce göziçi basınçları Tonopen XL ile ölçülerek kaydedildi. Enjeksiyondan 30 dakika, 2 saat, 3 saat, 5 saat ve 1 hafta sonra GİB ölçümü yapıldı. GİB değişikleri ile süre arasındaki ilişki iki yönlü varyans analizi ile değerlendirildi. Bulgular: Hastaların yaş ortalaması 61.7±6.9'du. Enjeksiyondan önce ortalama GİB'ı 18.3 ± 2.8 mm Hg idi. GİB, enjeksiyondan sonra, 30. dakikada 18.1 ± 3.6 mm Hg, 2.saatte 19.1 ± 2.9 mm Hg, 3. saatte 18.1 ± 3.3 mm Hg, 5. saatte 18.5± 3.4 mm Hg, 1. haftada 17.3 ± 2.4 mm Hg idi. Enjeksiyondan önce ve sonra belirtilen zamanlarda ölçülen ortalama GİB değerleri arasında istatistiksel olarak anlamlı fark yoktu. (p>0.05) Sonuç: Viterus içi 4 mg/0.1 ml triamsinolon asetonid enjeksiyonundan sonra erken dönemde GİB'nda belirgin artışlar ortaya çıkmamaktadır. Enjeksiyonlardan sonra ön kamara parasentezi gerekli değildir.

🔖

Cite This Article

EROL, N., BOZCA, T., YILDIRIM, N., TOPBAŞ, S. (2005). The effect of intravitreal triamcynolone injection on short term intraocular pressure. Retina-Vitreus, Cilt: 13 - Sayı: 3, 215–217. https://ajindex.com/articles/308115

References (15)

  1. Karaçorlu M, Özdemir H, Karacorlu S.: Intravitreal triamcinolone acetonide for the treatment of chronic pseudophacic cystoid macular oedema. Acta Ophthalmol Scand 2003; 81: 648-652
  2. Danis RP, Ciulla TA, Pratt LM, et al.: Intravitreal triamcinolone acetonide in exudative age-related macular degeneration.Retina 2000; 20: 244-250
  3. Antcliff RJ, Spalton DJ, Stanford MR et al. Intravitreal triamcinolone for uveitic cystoid macular oedema:an optical coherence tomography study. Ophthalmology 2001; 108: 765-772
  4. Karaçorlu M, Özdemir H, Alacalı N ve ark.: Diffüz diabetik makula ödemi tedavisinde intravitreal triamsinolon. T Oft Gaz 2003; 33: 488-497
  5. Karaçorlu M, Özdemir H, Karaçorlu S.: Santral retina ven tıkanıklığına bağlı makula ödemi tedavisinde intravitreal triamsinolon asetonid.T Oft Gaz. 2003; 33: 742-749
  6. Martidis A, Duker JS, Greenberg PB, et al.: İntravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology 2002; 109: 920-927
  7. Jonas JB, Hayler JK, Sofker A, et al.: Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative diabetic retinopathy. Am J Ophthalmol 2001; 131: 468-471
  8. Jonas JB, Kreissig I, Degenring R.: Intraocular pressure after intravitreal injection of triamcinolone acetonide. Br J Ophthalmol 2003; 87: 24-27
  9. Bakri SJ, Beer PM.: The effect of intravitreal triamcinolone acetonide on intraocular pressure. Ophthalmic Surg Lasers Imaging. 2003; 34: 386-390
  10. Moshfeghi DM, Kaiser PK, Scott IU, et al.: Acute endophthalmitis following intravitreal triamcinolone acetonide injection. Am J Ophthalmol 2003; 136: 791-796
  11. Spaide RF, Sorenson J, Maranan L: Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization. Ophthalmology 2003; 110; 1517-1525
  12. Tunç Ovalı.: Retina Dekolmanı. Nobel Tıp Kitabevi. Tayf Ofset. İstanbul. 2002: 93-101
  13. Jager RD, Aiello PL, Patel SC, et al.: Risks of intravitreous injection: A comprehensive review. Retina 2004; 24: 676-698
  14. Aiello LP, Brucker AJ, Chang S, et al. Evolving guidelines for intravitreous injections. Retina 2004; 24: S3-S19
  15. Park CH, Jaffe GJ, Fekrat S.: Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion. Am J Ophthalmol 2003; 136: 419-425.